Ali Shokoohmand
Positions
- Postdoctoral Research Fellow, APCRC-Q
- Member, IHBI
Contact Details
- a.shokoohmand@qut.edu.au
- Phone
- +614504 45848
- Linkedin profile
- https://au.linkedin.com/in/ali-shokoohmand-5592a2aa
Related websites and profiles
http://staff.qut.edu.au/staff/shokoohm/
Qualifications
- Doctor of Philosophy (PhD), Cell/Cellular and Molecular biology, Queensland University of Technology (QUT), July 2015
- Master of Biotechnology, Queensland University of Technology (QUT), 2010 – 2011 (Not completed)
- Bachelor of Biotechnology, Griffith University, 2008 -2010
- Bachelor of Applied Science (Microbiology and Cell/Cellular Biology), 2001 – 2006
Biography
Dr Ali Shokoohmand is early career research fellow at Australian Prostate Cancer Research Centre-Queensland (APCRC-Q) at Translational Research Institute (TRI), QUT, supporting tumor microenvironment research with a Movember Revolutionary Team Award (MRTA) that addresses advanced prostate cancer research. His research focuses on development and validation in vitro engineering of human-derived three dimensional (3D) prostate cancer tumour models to investigate androgen targeted therapies and rationalised co-targeting agents, and to identify novel molecular mechanisms underlying cellular and micro-environmental regulation of prostate cancer development and progression at different stages.
Awards and grants
Awards
|
2016 |
Merit Award, 10th World Biomaterials Congress (WBC), Canada |
|
2013 |
Travel Award, Gordon Research Conferences (GRC), IGF Society conference, USA |
|
2010 |
Dean's Merit Award, Queensland University of Technology |
Grants
|
2015-2016 |
Institute of Health and Biomedical education Early Career research Grant |
Identification of extracellular matrix-growth factor interactions and their mechanism of action in cancer progression |
Mentors: DW Hutmacher, D Loessner, B Hollier |
Research interests
Cell/Cellular and Molecular Biology, Cancer biology, Biomaterials of cancer
Current research projects
In vitro engineering of the human prostate tumor microenvironment
Top publications
Shokoohmand A, Loessner D, Holzapfel BM, Wagner F, Baldwin J, Rockstroh A, Magdolen V, Clements JA and Hutmacher DW. A bioengineered 3D approach to mimic the tumor-stroma microenvironment of ovarian cancer. Front. Bioeng. Biotechnol. 2016; Conference Abstract: 10th World Biomaterials Congress. 2016; doi: 10.3389/conf.FBIOE.2016.01.02987.
Muerza-Cascante ML, Shokoohmand A, Khosrotehrani K, Haylock D, Dalton PD, Hutmacher DW, & Loessner D. Endosteal-like extracellular matrix expression on melt electrospun written scaffolds. Accepted to Acta Biomaterialia. 2016.
Kashyap AS, Shooter GK, Shokoohmand A, McGovern J, Sivaramakrishnan M, Croll TI, Cane G, Leavesley D I, Söderberg O, Upton Z, & Hollier, B.G., 2016. Antagonists of IGF: Vitronectin interactions inhibit IGF-I-induced breast cancer cell functions. Molecular cancer therapeutics. 2016; doi: 10.1158/1535-7163.MCT-15-0907.
Dargaville TR, Hollier BG, Shokoohmand A, & Hoogenboom R. Poly (2-oxazoline) hydrogels as next generation three-dimensional cell supports. Cell adhesion & migration. 2014; 8(2), 88-93.
Leavesley, DI, Kashyap AS, Croll T., Sivaramakrishnan M, Shokoohmand A, Hollier BG, & Upton Z. Vitronectin—Master controller or micromanager?. IUBMB life. 2013; 65(10), 807-818.
Collaborators
- Brett Hollier Head, Invasion & Metastasis, APCRC-Q
- Colleen Nelson AM Executive Director, APCRC-Q
- Dietmar Hutmacher Professor, IHBI, QUT
- Elizabeth Williams Head, Tumour Models, APCRC-Q
- Judith Clements AC Scientific Director, APCRC-Q
- Nathalie Bock Postdoctoral Research Fellow, APCRC-Q
Dr Daniela Loessner
Dr Laura Bray
Dr Abbas Shafiee
Dr Tony Parker
Dr Pawel Sadowski
Dr Elena Juan Pardo
Professional memberships and associations
|
2011 – present |
Australian Society of Medical Research (ASMR) |
